Skip to main content

The Globe and Mail

Canopy Growth signs deal to supply Australian company with medical cannabis

It is the second international deal announced by Canopy this week.

Hand-out/Canopy Growth Corporation

Canopy Growth Corp. has signed an agreement with AusCann Group Holdings Ltd. to be its exclusive supplier of medical cannabis for the Australian market.

Canada's largest licensed cannabis producer says it will start with the transfer of a range of medicines for research and commercialization in Australia.

The deal allows Canopy to pursue other Australian opportunities.

Story continues below advertisement

The agreement follows a partnership deal last year that saw Canopy take stake in AusCann in exchange for expertise in a number of areas including production, quality assurance and operations.

It is the second international deal announced by Canopy this week.

On Monday, Canopy signed a deal to provide certain marijuana strains and seeds to Spanish pharmaceutical producer Alcaliber.

Andrew Willis: Why you shouldn't buy into the pot boom and bust (The Globe and Mail)
Report an error
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.